Supreme Court Temporarily Restores Mifepristone Access in Louisiana Case

The U.S. Supreme Court on Monday temporarily restored broad access to mifepristone, the abortion pill, by issuing an emergency stay against a lower court ruling that had eliminated mail and pharmacy distribution nationwide. The decision came three days after a Fifth Circuit panel imposed the restrictions on May 1.

Briefs in the case are due May 7, with the justices set to consider competing applications from Louisiana and the drug's manufacturers. This marks the second time in recent years the Supreme Court has addressed challenges to FDA regulations on mifepristone.

In a 2024 ruling, the court unanimously dismissed a similar challenge on standing grounds, finding plaintiffs lacked a direct connection to the regulations.

Louisiana argues it has standing due to a 'sovereign injury,' claiming mailed pills undermine its ability to enforce its abortion ban. Legal experts, however, suggest this theory may face skepticism similar to the 2024 case. She noted it relies on potential Medicaid reimbursements for treating patients who have taken mifepristone, which is further removed from direct injury.

The case places the Trump administration in a difficult position, requiring the Justice Department to decide whether to defend the FDA's regulations on the merits or take a procedural stance that allows the restrictions to stand. Anti-abortion groups have expressed impatience with the administration's slow review of the drug, announced in September 2025.

Mary Ziegler, a constitutional law professor at the University of California, Davis, told Newsweek that conservative states are taking matters into their own hands due to the administration's delays. She predicted the case could drag on, keeping abortion issues prominent through the midterm elections.

Polling data indicates broad opposition to nationwide restrictions on mifepristone. Two KFF surveys from late 2025 found about two-thirds of Americans oppose a ban, while a Gallup poll in May 2025 showed 51 percent identifying as pro-choice, with a significant gender gap.

Comparison to 2022 Midterms The environment for Republicans appears more challenging than in 2022, following the Dobbs decision that overturned Roe v. Wade. That ruling drove high turnout and voter shifts toward Democrats on abortion issues. In 2025 off-year elections, Democrats achieved strong victories in states like Virginia and New Jersey, with women breaking heavily in their favor.

Ziegler noted that abortion headwinds are compounding other Republican challenges, including President Trump's approval ratings in the 34 to 40 percent range. The Supreme Court could dismiss the case on standing, schedule merits arguments for later in the year, or uphold the Fifth Circuit's restrictions.

Any path is likely to keep the issue alive through November, affecting Republican strategies in defending Senate seats and flipping the House.

“It's hard to see a scenario where this just goes away as a political issue." — Mary Ziegler, constitutional law professor at the University of California, Davis, to Newsweek The Guardian reported on the broader impacts of post-Dobbs abortion bans, noting that some states have implemented restrictions without exceptions for rape or incest, leading to clinic closures and challenges for women's health. However, it framed these developments as part of a larger pattern of diminishing women's rights, contrasting with Newsweek's focus on legal and political dynamics.”